Allogeneic Therapeutic Articles & Analysis
7 news found
However, there are a number of challenges that must be addressed in order to deliver on the promise of large-scale allogeneic cell therapy. Creating an effective therapeutic not only requires intimate knowledge of the disease being targeted, but also deep understanding of the processes required to generate the most relevant cell type to treat the disease, and the ...
Preclinical data demonstrate the use of gene circuits to improve the therapeutic potential of allogeneic CAR-NK cells for the treatment of solid tumors CAR-NK cells armed with calibrated release IL-15 achieve optimal cytokine distribution and result in superior killing and persistence Senti Bio, a leading gene circuit company, today announced new data ...
Cellphire Therapeutics, Inc., a biotechnology company developing next-generation allogeneic cellular therapeutics for application across multiple medical indications, announced today the appointment of Roy A. ...
Cellphire Therapeutics, Inc., a clinical stage biotechnology company developing next-generation allogeneic cellular therapeutics announced today the appointment of W. ...
Cellphire Therapeutics, Inc., a biotechnology company developing next-generation allogeneic cellular therapeutics for application across multiple medical indications, announced today the appointment of Pamela B. ...
Cellphire Therapeutics, Inc., a biotechnology company developing next-generation allogeneic cellular therapeutics for application across multiple medical indications, announced today that Angie Howerton, CPA, has joined the company as Vice President of Finance, Controller and Treasurer, effective immediately. ...
In addition to its current focus, BlueRock Therapeutics’ platform brings the opportunity to extend to other therapeutic areas beyond the current development programs. ...